Citations

Showing 10 of 108119 citations.

Editorial for “Short‐Term Repeatability of In Vivo Cardiac Intravoxel Incoherent Motion (IVIM) Tensor Imaging in Healthy Human Volunteers”
Zhou, Yuxiang , Jokerst, Clinton, Panda, Anshuman , Zhou, Yuxiang

Mayo Clinic

Journal of Magnetic Resonance Imaging | November 19, 2021 | Volume: 55 | Issue: 6 | Pages: 1853-1854

10.1002/jmri.28001 | PMID 34797000 Get It

Anti-NMDAR encephalitis presenting after immature teratoma resection
Chetram, Deandra Kimberly, Pan, Kelsey , Elfasi, Aisha , Chetram, Deandra , Markham, Merry Jennifer

Mayo Clinic

BMJ Case Reports | November 19, 2021 | Volume: 14 | Issue: 11 | Pages: e244637

10.1136/bcr-2021-244637 | PMID 34799390 Get It

This is a case of a young woman who developed neurological and psychiatric symptoms 3 days after resection of an immature teratoma. She was diagnosed with anti-NMDA receptor encephalitis via positive serum antibody titres, which was later confirmed with cerebrospinal fluid antibody titres. Given her cancer diagnosis, she underwent treatment with bleomycin, etoposide and cisplatin chemotherapy in addition to 5 days of high-dose steroids (1 g of intravenous methylprednisolone) for the encephalitis. This treatment regimen led to significant clinical improvement 3 weeks after completion of one cycle of chemotherapy.
Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF
Mooney, Leanne , Hawkins, Nathaniel M. , Jhund, Pardeep S. , Redfield, Margaret M. , Vaduganathan, Muthiah , Desai, Akshay S. , Rouleau, Jean L. , Minamisawa, Masatoshi, Shah, Amil M. , Lefkowitz, Martin, Veldhuisen, Dirk J. van , Maggioni, Aldo P. , Claggett, Brian , Solomon, Scott D. , McMurray, John J.V. , Zile, Michael R , Van Veldhuisen, Dirk J , Pfeffer, Marc Alan , Anand, Inder S , Maggioni, Aldo P , Claggett, Brian L , Solomon, Scott David , McMurray, John J V , Jhund, Pardeep S , Desai, Akshay S , Shah, Amil , Zile, Michael R. , Anand, Inder S. , Senni, Michele , Vaduganathan, Muthiah

Mayo Clinic

Journal of the American Heart Association | November 19, 2021 | Volume: 10 | Issue: 23 | Pages: No page available

10.1161/jaha.121.021494 | PMID 34796742 Get It

Background Little is known about the impact of chronic obstructive pulmonary disease (COPD) in patients with heart failure with preserved ejection fraction (HFpEF). Methods and Results We examined outcomes in patients with heart failure with preserved ejection fraction, according to COPD status, in the PARAGON‐HF (Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor With Angiotensin Receptor Blocker Global Outcomes in Heart Failure With Preserved Ejection Fraction) trial. The primary outcome was a composite of first and recurrent hospitalizations for heart failure and cardiovascular death. Of 4791 patients, 670 (14%) had COPD. Patients with COPD were more likely to be men (58% versus 47%; P <0.001) and had worse New York Heart Association functional class (class III/IV 24% versus 19%), worse Kansas City Cardiomyopathy Questionnaire Clinical Summary Scores (69 versus 76; P <0.001) and more frequent history of heart failure hospitalization (54% versus 47%; P <0.001). The decrement in Kansas City Cardiomyopathy Questionnaire Clinical Summary Scores with COPD was greater than for other common comorbidities. Patients with COPD had echocardiographic right ventricular enlargement, higher serum creatinine (100 μmol/L versus 96 μmol/L) and neutrophil‐to‐lymphocyte ratio (2.7 versus 2.5), than those without COPD. After multivariable adjustment, COPD was associated with worse outcomes: adjusted rate ratio for the primary outcome 1.51 (95% CI, 1.25–1.83), total heart failure hospitalization 1.54 (95% CI, 1.24–1.90), cardiovascular death (adjusted hazard ratio [HR], 1.42; 95% CI, 1.10–1.82), and all‐cause death (adjusted HR, 1.52; 95% CI, 1.25–1.84). COPD was associated with worse outcomes than other comorbidities and Kansas City Cardiomyopathy Questionnaire Clinical Summary Scores declined more in patients with COPD than in those without. Conclusions Approximately 1 in 7 patients with heart failure with preserved ejection fraction had concomitant COPD, which was associated with greater functional limitation and a higher risk of heart failure hospitalization and death. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01920711 .
Humoral Immunogenicity of mRNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease and Healthy Controls
Caldera, Freddy , Knutson, Keith L. , Saha, Sumona , Wald, Arnold , Phan, Hiep , Chun, Kelly , Grimes, Ian, Lutz, Megan , Caldera, Freddy , Knutson, Keith L. , Hayney, Mary S. , Farraye, Francis A.

Mayo Clinic

American Journal of Gastroenterology | November 19, 2021 | Volume: 117 | Issue: 1 | Pages: 176-179

10.14309/ajg.0000000000001570 | PMID 34797219 Get It

INTRODUCTION: Patients with inflammatory bowel disease (IBD) on immune-modifying therapies may have a lower vaccine response to certain vaccines. The aim of our study was to evaluate humoral immunogenicity of mRNA coronavirus disease 2019 (COVID-19) vaccines among patients with IBD and healthy controls (HCs). METHODS: We performed a prospective study to evaluate humoral immunogenicity among patients with IBD and HCs after completion of mRNA COVID-19 vaccines. RESULTS: One hundred twenty-two patients with IBD and 60 HCs were enrolled. All HCs and 97% of patients with IBD developed antibodies. Antibody concentrations were lower in patients with IBD compared with those in HCs (median 31 vs 118 μg/mL; P < 0.001). Those who received the mRNA-1273 (Moderna) COVID-19 (median 38; interquartile range [IQR] 24–75 vs μg/mL) had higher antibody concentrations compared with those who received the Pfizer-BNT vaccine series (median 22; IQR 11–42 μg/mL; P < 0.001). Patients on immune-modifying therapy (median 26; IQR 13–50 μg/mL) had lower antibody concentrations compared with those who were on no treatment, aminosalicylates, or vedolizumab (median 59; IQR 31–75 μg/mL; P = 0.003). DISCUSSION: Almost all patients with IBD in our study mounted an antibody response. Future studies are needed in evaluating sustained humoral immunity and the impact of booster dosing in patients with IBD.
Preventiometer, a Novel Wellness Assessment Device, Used With Healthy Volunteers: A Phase 2 Study
Nanda, S. , Chon, Tony Y. , Mahapatra, Saswati , Lindeen, Stephanie A. , Krüger, Markus , Schierwater, Bernd , Wahner‐Roedler, Dietlind L. , Bauer, Brent A. , Nanda, Sanjeev , Schmidt, Carsten O, Wahner-Roedler, Dietlind L , Mahapatra, Saswati , Fischer, Karen M. , Schmidt, Carsten Oliver

Mayo Clinic

Global Advances in Health and Medicine | November 19, 2021 | Volume: 10 | Issue: No issue available | Pages: No page available

10.1177/21649561211045016 | PMID 34840917 Get It

Background We previously reported on a pilot study to assess the incorporation of a novel wellness assessment device, the Preventiometer (iPEx5 GmbH, Greifswald, Germany), into an academic medical practice. The present follow-up study expands on those data and evaluates the acceptability of the assessment process in a larger sample population. Objective The aim of this study was to evaluate participant satisfaction with the Preventiometer wellness assessment. Methods A total of 60 healthy volunteers participated. Each participant underwent a comprehensive wellness assessment with the Preventiometer and received data from more than 30 diagnostic tests. A 32-question survey (with a numeric rating scale from 0 to 10) was used to rate the wellness assessment tests and participants’ impressions of the wellness assessment. Results Each assessment had a significantly higher rating than 7 ( P < .001), and the majority of participants agreed or strongly agreed that they were satisfied (98.3%), and they strongly agreed that they were engaged the entire time (93.2%), and liked the instant test results feature of the Preventiometer device (93.2%). Conclusion This study confirms findings from our previous pilot study regarding the feasibility of the Preventiometer as a wellness assessment tool. The study further demonstrated that 98% of participants were satisfied with the assessment and that all of them would recommend it to others.
The Use of New Emerging Technology in Echocardiography-Glass View
Alhasan, Faysal, Arsanjani, Reza , Alsidawi, Said , Arsanjani, Reza , Alsidawi, Said

Mayo Clinic

Korean Circulation Journal | November 19, 2021 | Volume: 52 | Issue: 1 | Pages: 87

10.4070/kcj.2021.0341 | PMID 34989196 Get It

Role of anisotropy in elastographic tissue characterization
Pelissero, Maureen, Urban, Matthew W. , Liu, Hsiao‐Chuan

Mayo Clinic

The Journal of the Acoustical Society of America | November 18, 2021 | Volume: 150 | Issue: 4_Supplement | Pages: A287-A287

10.1121/10.0008315 Get It

The structure and function of soft tissues are intimately connected. Some soft tissues are organized in such a way that they have material properties that are anisotropic, that is, the measured properties depend on which direction they are measured. Some such tissues are the brain, kidney, arteries, and cardiac and skeletal muscle. We will provide a brief overview of work targeted at characterization of the anisotropic mechanical properties in kidney and cardiac and skeletal muscles. In many cases, these tissues can be assumed to be transversely isotropic, which allows for simplification in estimating their mechanical properties. The use of propagating shear waves can be used to determine these mechanical properties. As a comparison example, we will show data from characterization of renal tissue with ultrasound shear wave elastography (SWE) and optical coherence elastography. We will also provide an overview of evaluation of skeletal muscle mechanical properties using shear wave elastography techniques and use of model fitting to estimate mechanical properties. Special care must be taken in evaluation of such anisotropic tissues to ensure that measurements are standardized across practices and studies.
Ocular biomechanics and glaucoma
Kazemi, Arash , Sit, Arthur J. , Zhang, Xiaoming

Mayo Clinic

The Journal of the Acoustical Society of America | November 18, 2021 | Volume: 150 | Issue: 4_Supplement | Pages: A166-A166

10.1121/10.0008003 Get It

Glaucoma is the leading cause of irreversible blindness worldwide. Ocular biomechanical properties have been implicated in glaucoma pathogenesis, but existing commercial devices cannot determine changes in specific tissues. We recently performed a study to compare corneal wave speed (a measure of corneal elasticity) and ocular rigidity (a whole eye measurement of ocular biomechanics) between glaucomatous and normal eyes. Twenty glaucomatous eyes from 10 patients and 20 normal eyes from 13 controls, matched for age, intraocular pressure (IOP), and axial length were included. Ocular rigidity was calculated based on the difference in supine IOP by pneumatonometry with and without a 10-g weight. Corneal wave speed was determined by ultrasound surface wave elastography in which a small, 0.1 s harmonic vibration at 100 Hz was generated through the closed eyelids. Wave propagation was captured by an ultrasound transducer, and wave speed was determined from the phase change with distance. No significant differences in corneal wave speed between glaucomatous and normal eyes were detected (P = 0.17). However, ocular rigidity was significantly lower in glaucomatous eyes (0.0218 ± 0.0033 vs 0.0252 ± 0.0050 μl−1, P = 0.01). While lower ocular rigidity is consistent with altered biomechanics in glaucoma, the lack of a difference in corneal wave speed suggests that corneal tissue may not be significantly affected, and scleral changes likely play a more important role.
An ultrasound vibro-elastography technique for assessing papilledema
Kazemi, Arash , Chen, John J. , Zhou, Boran , Sit, Arthur J. , Zhang, Xiaoming

Mayo Clinic

The Journal of the Acoustical Society of America | November 18, 2021 | Volume: 150 | Issue: 4_Supplement | Pages: A166-A167

10.1121/10.0008004 Get It

Papilledema is optic nerve swelling caused by increased intracranial hypertension, which has the potential to cause significant vision loss. Papilledema from idiopathic intracranial hypertension (IIH) is typically bilateral and symmetric, but can sometimes be asymmetric and even unilateral. The cause for this asymmetry is unknown. The purpose of this study was to develop ultrasound vibro-elastography (UVE) for assessing patients with papilledema to evaluate for biomechanical differences in these eyes. Nine patients with papilledema from IIH and 9 age-matched healthy control subjects were enrolled. A local harmonic vibration was used to generate wave propagation through the eyelid. Three excitation frequencies of 100, 150, and 200 Hz were used. A 6.4 MHz ultrasound probe was used to measure wave propagation in the eye structures. Wave speeds were measured in the posterior sclera of the maculae. The magnitudes of the wave speed of the IIH patients’ posterior sclera were significantly higher than those of healthy subjects. In patients with unilateral papilledema, the wave speed of the posterior sclera were higher in the eyes with papilledema than in the contralateral eyes without papilledema. UVE provides a noninvasive technique to measure the wave speed of posterior sclera, which is stiffer in eyes with papilledema.
Evaluation of Burnout in a National Sample of Hematology-Oncology Pharmacists
Golbach, Allison P. , McCullough, Kristen , Soefje, Scott A. , Mara, Kristin C. , Shanafelt, Tait D. , Merten, Julianna A., McCullough, Kristen B , Shanafelt, Tait D , Mara, Kristin C , Soefje, Scott A , Golbach, Allison P. , Merten, Julianna A.

Mayo Clinic

JCO Oncology Practice | November 18, 2021 | Volume: 18 | Issue: 8 | Pages: e1278-e1288

10.1200/op.21.00471 | PMID 34793242 Get It

PURPOSE: To evaluate the prevalence of burnout among hematology-oncology pharmacists and factors associated with an increased risk of high burnout. METHODS: Between October and November 2020, members of the Hematology/Oncology Pharmacy Association were invited to complete an anonymous survey. Questions included the Maslach Burnout Inventory (MBI), Well-Being Index, and sociodemographic and occupational factors linked with burnout. RESULTS: Of 3,024 pharmacists contacted, 614 pharmacists (20.3%) responded to an online survey and 550 (18.2% of overall sample) completed the MBI and were included for analysis. Overall, high levels of burnout were observed in 61.8% of respondents based on the MBI, with 57.9% of respondents scoring high on the emotional exhaustion domain and 31.3% high in the depersonalization domain. Pharmacists with burnout worked on average 48.6 (±9.6) hours per week compared with 44.5 (±9.6) hours per week for those without high burnout and spent more time on administrative tasks per week (7.5 hours v 4.3 hours; all P < .001). Pharmacists reporting high burnout were more likely to report concern they had made a major medication error within the past 3 months (27.6% v 8.1%; P < .001) and greater intent to leave their current job within 2 years (60.3% v 19.0%; P < .001). CONCLUSION: Burnout is prevalent among hematology-oncology pharmacists and may affect both patient safety and the adequacy of the workforce. Risk factors for burnout among hematology-oncology pharmacists in this study may be targets for burnout mitigation and prevention strategies to reduce the impact on pharmacists and improve cancer care for patients.